Image (Image 01)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1776
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-1776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 02)
This is a comparison of the adverse reactions of diltiazem hydrochloride extended-release capsules and placebo in a combined study of angina and hypertension trials. The study found that compared to the placebo, diltiazem hydrochloride had higher incidence rates of headache, bradycardia, AV block, edema, and asthenia. The percentage rates for each adverse reaction are provided in a table.*
Label (Lbl713351776)
This text refers to a medication named Diltiazem HCI ER presented in blue capsules of 180mg. It's manufactured by Novast Laboratories Ltd, and it's recommended to be stored at a room temperature of 20°-25°C. The medicine comes in a package of 30 capsules with an expiration date that's represented by MM/YY. Additionally, it contains a warning to keep it out of the reach of children. It also shows some barcode and identification numbers such as NDC 7133517761 and 07232301523487.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
